ClinicalTrials.Veeva

Menu

Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis

A

Air Force Military Medical University of People's Liberation Army

Status

Enrolling

Conditions

Ulcerative Colitis

Treatments

Device: Sacral nerve stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT07114159
KY20232100-extension

Details and patient eligibility

About

Although the incidence of inflammatory bowel disease is stable in North American and European countries, the incidence of inflammatory bowel disease is increasing in newly industrialized countries, especially in China. The treatment drugs for ulcerative colitis include 5-aminosalicylic acid (5-ASA), glucocorticoids, immunosuppressants, and biological agents. The aim of this clinical trial is to evaluate the long-term safety and efficacy of sacral nerve stimulation in patients with ulcerative colitis

Enrollment

15 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 18-65 years
  • ulcerative colitis diagnosed for at least 3 mouths.
  • Mayo score 6-12, Mayo endoscopic score 2-3 points
  • resistant to medical treatment

Exclusion criteria

  • Treatment-naive ulcerative colitis (no previous treatment)
  • Acute severe ulcerative colitis
  • Currently taking any biologicals
  • Previous surgical treatment or severe colitis at imminent risk of surgery
  • infective colitis
  • Other systemic diseases
  • Pregnancy and lactation

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Sacral nerve stimulation
Experimental group
Treatment:
Device: Sacral nerve stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Jian Wan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems